BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31983379)

  • 21. Regression of a cardiac rhabdomyoma in a patient receiving everolimus.
    Tiberio D; Franz DN; Phillips JR
    Pediatrics; 2011 May; 127(5):e1335-7. PubMed ID: 21464184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.
    Mohamed I; Ethier G; Goyer I; Major P; Dahdah N
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25427930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
    French JA; Lawson JA; Yapici Z; Ikeda H; Polster T; Nabbout R; Curatolo P; de Vries PJ; Dlugos DJ; Berkowitz N; Voi M; Peyrard S; Pelov D; Franz DN
    Lancet; 2016 Oct; 388(10056):2153-2163. PubMed ID: 27613521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial.
    Randell E; McNamara R; Davies DM; Owen-Jones E; Kirby N; Angel L; Drew C; Cannings-John R; Smalley M; Saxena A; McDermott E; Stockwell L; de Vries PJ; Hood K; Sampson JR
    Trials; 2016 Aug; 17():398. PubMed ID: 27515417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.
    Sciacca P; Giacchi V; Mattia C; Greco F; Smilari P; Betta P; Distefano G
    BMC Cardiovasc Disord; 2014 May; 14():66. PubMed ID: 24884933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
    Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Berkowitz N; Anak O; Niolat J; Jozwiak S
    Lancet Oncol; 2014 Dec; 15(13):1513-1520. PubMed ID: 25456370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Whittemore VH; Chen D; Sahmoud T; Shah G; Lincy J; Lebwohl D; Budde K
    Lancet; 2013 Mar; 381(9869):817-24. PubMed ID: 23312829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
    Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature.
    Benyounes N; Fohlen M; Devys JM; Delalande O; Moures JM; Cohen A
    Arch Cardiovasc Dis; 2012; 105(8-9):442-5. PubMed ID: 22958887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature.
    Martínez-García A; Michel-Macías C; Cordero-González G; Escamilla-Sánchez KI; Aguinaga-Ríos M; Coronado-Zarco A; Cardona-Pérez JA
    Cardiol Young; 2018 Jul; 28(7):903-909. PubMed ID: 29759095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of everolimus for cardiac rhabdomyomas in a very-low-birthweight infant.
    Tsuchihashi T; Tsuno Y; Kakimoto N; Riko M; Kumagai T
    Pediatr Int; 2021 Jun; 63(6):726-727. PubMed ID: 34038023
    [No Abstract]   [Full Text] [Related]  

  • 32. Sirolimus Can Increase the Disappearance Rate of Cardiac Rhabdomyomas Associated with Tuberous Sclerosis: A Prospective Cohort and Self-Controlled Case Series Study.
    Chen XQ; Wang YY; Zhang MN; Lu Q; Pang LY; Liu LY; Li YF; Zou LP
    J Pediatr; 2021 Jun; 233():150-155.e4. PubMed ID: 33631166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial.
    Curatolo P; Franz DN; Lawson JA; Yapici Z; Ikeda H; Polster T; Nabbout R; de Vries PJ; Dlugos DJ; Fan J; Ridolfi A; Pelov D; Voi M; French JA
    Lancet Child Adolesc Health; 2018 Jul; 2(7):495-504. PubMed ID: 30169322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid regression of large cardiac rhabdomyomas in neonates after sirolimus therapy.
    Weiland MD; Bonello K; Hill KD
    Cardiol Young; 2018 Mar; 28(3):485-489. PubMed ID: 29233209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
    Saffari A; Brösse I; Wiemer-Kruel A; Wilken B; Kreuzaler P; Hahn A; Bernhard MK; van Tilburg CM; Hoffmann GF; Gorenflo M; Hethey S; Kaiser O; Kölker S; Wagner R; Witt O; Merkenschlager A; Möckel A; Roser T; Schlump JU; Serfling A; Spiegler J; Milde T; Ziegler A; Syrbe S
    Orphanet J Rare Dis; 2019 May; 14(1):96. PubMed ID: 31053163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autopsy case of right ventricular rhabdomyoma in tuberous sclerosis complex.
    Kondo T; Niida Y; Mizuguchi M; Nagasaki Y; Ueno Y; Nishimura A
    Leg Med (Tokyo); 2019 Feb; 36():37-40. PubMed ID: 30336374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
    Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac involvement in tuberous sclerosis.
    Mühler EG; Turniski-Harder V; Engelhardt W; von Bernuth G
    Br Heart J; 1994 Dec; 72(6):584-90. PubMed ID: 7857744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New-onset cardiac rhabdomyoma beyond infancy in a patient with tuberous sclerosis complex.
    Thatte NM; Guleserian KJ; Veeram Reddy SR
    Cardiol Young; 2016 Feb; 26(2):396-9. PubMed ID: 26169191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus as a possible prenatal treatment of in utero diagnosed subependymal lesions in tuberous sclerosis complex: a case report.
    Cavalheiro S; da Costa MDS; Richtmann R
    Childs Nerv Syst; 2021 Dec; 37(12):3897-3899. PubMed ID: 34008055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.